** Shares of medtech firm Senseonics Holdings SENS.A down a penny post-market to 54 cents as it looks to raise equity
** Germantown, Maryland-based maker of continuous glucose monitoring (CGM) systems commences $50 mln public offering
** Co says Abbott Laboratories ABT.N agreed to buy up to $25 mln of shares in concurrent private placement
** It intends to use net proceeds from both transactions to fund ongoing launch of Eversense 365, and continued development of its pipeline
** TD Cowen and Barclays are jt-lead bookrunners for proposed offering, joined by RBC and Lake Street
** Senseonics has ~654.3 mln shares outstanding and ~585.1 mln shares of free float, per LSEG data
** SENS fell for 5th straight day on Thurs. Stock well off its 52-week high of $1.40 hit in mid-Feb
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。